Vitamin B6 is essential for serine de novo biosynthesis. Issue 6 (11th August 2017)

• Record Type: Journal Article
• Authors: Ramos, Rúben J.; Pras‐Raves, Mia L.; Gerrits, Johan; van der Ham, Maria; Willemsen, Marcel; Prinsen, Hubertus; Burgering, Boudewijn; Jans, Judith J.; Verhoeven‐Duif, Nanda M.
• Is Part Of: Journal of inherited metabolic disease. Volume 40:Issue 6(2017)
• Page Start: 883
• Page End: 891
• Publication Date: 2017-08-11
• Subjects: Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1007/s10545-017-0061-3
• Languages: English
• ISSNs: 0141-8955

Abstract

Abstract: Pyridoxal 5′‐phosphate (PLP), the metabolically active form of vitamin B6, plays an essential role in brain metabolism as a cofactor in numerous enzyme reactions. PLP deficiency in brain, either genetic or acquired, results in severe drug‐resistant seizures that respond to vitamin B6 supplementation. The pathogenesis of vitamin B6 deficiency is largely unknown. To shed more light on the metabolic consequences of vitamin B6 deficiency in brain, we performed untargeted metabolomics in vitamin B6‐deprived Neuro‐2a cells. Significant alterations were observed in a range of metabolites. The most surprising observation was a decrease of serine and glycine, two amino acids that are known to be elevated in the plasma of vitamin B6 deficient patients. To investigate the cause of the low concentrations of serine and glycine, a metabolic flux analysis on serine biosynthesis was performed. The metabolic flux results showed that the de novo synthesis of serine was significantly reduced in vitamin B6‐deprived cells. In addition, formation of glycine and 5‐methyltetrahydrofolate was decreased. Thus, vitamin B6 is essential for serine de novo biosynthesis in neuronal cells, and serine de novo synthesis is critical to maintain intracellular serine and glycine. These findings suggest that serine and glycine concentrations in brain may be deficient in patients with vitamin B6 responsive epilepsy. The low intracellular 5‐mTHF concentrations observed in vitro may explain the favourable but so far unexplained response of some patients with pyridoxine‐dependent epilepsy to folinic acid supplementation.